Renal cell carcinoma for the nephrologist

被引:82
作者
Perazella, Mark A. [1 ,2 ]
Dreicer, Robert [3 ]
Rosner, Mitchell H. [4 ]
机构
[1] Yale Univ, Sch Med, Sect Nephrol, 333 Cedar St, New Haven, CT 06520 USA
[2] Vet Affairs Med Ctr, West Haven, CT USA
[3] Univ Virginia Hlth Syst, Div Hematol Oncol, Charlottesville, VA USA
[4] Univ Virginia Hlth Syst, Div Nephrol, Charlottesville, VA USA
关键词
acute kidney injury; chronic kidney disease; immunotherapy; nephrotoxicity; renal cell carcinoma; targeted anticancer agents; von Hippel-Lindau; CHRONIC KIDNEY-DISEASE; TUMOR-SUPPRESSOR GENE; VON-HIPPEL-LINDAU; NEPHRON-SPARING SURGERY; HOGG-DUBE-SYNDROME; CANCER-SPECIFIC MORTALITY; PHASE-III TRIAL; PARTIAL NEPHRECTOMY; RADICAL NEPHRECTOMY; URINARY-TRACT;
D O I
10.1016/j.kint.2018.01.023
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal cell carcinoma (RCC), a malignancy whose incidence is increasing, is frequently encountered in general nephrology practice when acute and chronic kidney disease occurs in the course of disease. Importantly, when kidney disease develops in the setting of RCC, mortality is significantly increased with patients often dying of a non-cancer-related complication of kidney disease. As such, practicing nephrologists need to have a working knowledge of this cancer's biology, treatment, and complications. Nephrologists should be involved in all aspects of the care of patients with RCC including in the acute setting prior to nephrectomy and in the chronic setting for patients with post-nephrectomy chronic kidney disease and those receiving potentially nephrotoxic anticancer agents. This collaborative approach to RCC care will hopefully improve patient outcomes.
引用
收藏
页码:471 / 483
页数:13
相关论文
共 152 条
[1]   Cancer risk following organ transplantation:: a nationwide cohort study in Sweden [J].
Adami, J ;
Gäbel, H ;
Lindelöf, B ;
Ekström, K ;
Rydh, B ;
Glimelius, B ;
Ekbom, A ;
Adami, HO ;
Granath, F .
BRITISH JOURNAL OF CANCER, 2003, 89 (07) :1221-1227
[2]  
[Anonymous], FED REG
[3]  
[Anonymous], Cancer Stat Facts: Kidney and Renal Pelvis Cancer
[4]  
[Anonymous], 2000, TRANSPL INT
[5]   Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling [J].
Baba, Masaya ;
Hong, Seung-Beom ;
Sharma, Nirmala ;
Warren, Michelle B. ;
Nickerson, Michael L. ;
Iwamatsu, Akihiro ;
Esposito, Dominic ;
Gillette, William K. ;
Hopkins, Ralph F., III ;
Hartley, James L. ;
Furihata, Mutsuo ;
Oishi, Shinya ;
Zhen, Wei ;
Burke, Terrence R., Jr. ;
Linehan, W. Marston ;
Schmidt, Laura S. ;
Zbar, Berton .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (42) :15552-15557
[6]   Advances in medical imaging for the diagnosis and management of common genitourinary cancers [J].
Bagheri, Mohammad H. ;
Ahlman, Mark A. ;
Lindenberg, Liza ;
Turkbey, Baris ;
Lin, Jeffrey ;
Civelek, Ali Cahid ;
Malayeri, Ashkan A. ;
Agarwal, Piyush K. ;
Choyke, Peter L. ;
Folio, Les R. ;
Apolo, Andrea B. .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (07) :473-491
[7]   VHL and HIF signalling in renal cell carcinogenesis [J].
Baldewijns, Marcella M. ;
van Vlodrop, Iris J. H. ;
Vermeulen, Peter B. ;
Soetekouw, Patricia M. M. B. ;
van Engeland, Manon ;
de Bruine, Adriaan P. .
JOURNAL OF PATHOLOGY, 2010, 221 (02) :125-138
[8]   Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis [J].
Barlow, LaMont J. ;
Korets, Ruslan ;
Laudano, Melissa ;
Benson, Mitchell ;
McKiernan, James .
BJU INTERNATIONAL, 2010, 106 (04) :489-492
[9]   The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis [J].
Barry, RE ;
Krek, W .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (09) :466-472
[10]   MALIGNANCIES OF URINARY-TRACT AND THEIR RELATION TO ANALGESIC ABUSE [J].
BENGTSSON, U ;
JOHANSSON, S ;
ANGERVALL, L .
KIDNEY INTERNATIONAL, 1978, 13 (01) :107-113